成都治疗前列腺肥大哪好成都静脉曲张手术费用是多少,在成都治疗静脉曲张要花费多少钱,成都下肢静脉血栓治疗上哪家好,成都脉管畸形手术好吗,成都大隐静脉曲张微创手术价格,成都治疗血管瘤的专业医院,成都静脉扩张最好的治疗

Genetic testing company 23andMe has been given federal approval to sell at-home kits that test for three breast cancer gene mutations.This will be the first direct-to-consumer DNA test for these particular breast cancer gene mutations, the Food and Drug Administration said on Tuesday.A spokeswoman for 23andMe said the test for the three BRCA1/BRCA2 breast cancer gene mutations will be added "in the coming weeks" to the broader Health + Ancestry services, with no increase to the existing 9 cost.The test can only detect three out of more than 1,000 known BRCA mutations, according to the FDA. The BRCA1/BRCA2 hereditary mutations occur in about 2% of Ashkenazi Jewish women, but rarely occur in anyone else, the agency said in a press release."The test also does not provide information on a person's overall risk of developing any type of cancer," the FDA added.23sandMe already tests for genetic health risks for diseases like Parkinson's and Alzheimer's, along with wellness reports for things like lactose intolerance and saturated fat, and ancestral composition including Neanderthal ancestry.In 2013, the FDA ordered the company to stop sales of its home-testing kits, saying the Alphabet-backed company had failed to prove the validity of its product.Related: 23andMe gets funding for drug developmentAnne Wojcicki, who founded the company in 2006, called the FDA shutdown a "transformative moment" that prompted 23andMe to branch into drug development."Thank you to the FDA for hard work and progress on innovation," she tweeted on Tuesday.In 2015, 23andMe received approval from the FDA to test customers for whether they are carriers of certain disease-carrying genes that could be passed on to their children. In early 2017, the company received approval to issue genetic health risk reports.In September of last year, the company said it received 0 million in funding from Sequoia Capital to develop drugs based on user DNA.The-CNN-Wire? & ? 2018 Cable News Network, Inc., a Time Warner Company. All rights reserved. 2050

Here’s just a few of the #BlackVoicesForTrump at tonight’s rally! Having a fantastic time!#TulsaRally2020 #Trumptulsa #TulsaTrumprally #MAGA #Trump2020 #Trump2020Landslide pic.twitter.com/27mUzkg7kL— Herman Cain (@THEHermanCain) June 20, 2020 251

Health officials say the U.S. faces an uphill battle in convincing some Americans to take a potential COVID-19 vaccine. While polling shows Americans have been more open to a vaccine in recent months, there is still skepticism in vaccines among non-whites across the country.Experts say that Black people, in particular, remain skeptical of vaccines due to past failings of the U.S. healthcare system, in particular, the Tuskegee syphilis study. But the National Medical Association — a nonprofit representing the interests of Black doctors across the country — is trying to fight that skepticism ahead of the potential authorization of a COVID-19 vaccine."We're already suffering more than other community, and we would hate to see that suffering gap widen because members of our community did not affect to receive a vaccine that could have prevented kidney disease, prevented lung damage from COVID-19," Dr. Leon McDougle, the president of the National Medical Association said.The National Medical Association's task force has been doing its own independent vetting of potential COVID-19 vaccines, and McDougle added they are doing so to ensure that politicians are not influencing the Food and Drug Administration (FDA)."We are trusted messengers for health in the Black community," McDougle said. "That's where we live. That's where we work, and we already have those established relationships."The group has already had two meetings with Pfizer — the company, who on Wednesday, said it is days away from filing for Emergency Use Authorization for its vaccine candidate — and has a third meeting planned.The Association has also met with Moderna and AstraZeneca about their vaccine trials.McDougle added that since the group has been having meetings with vaccine makers for a while, he's hopeful the Association will agree with the FDA's decisions.McDougle says the National Medical Association has already been collaborating with clergy and other professional organizations that are looking to them for a direction on the vaccine. 2045

Heads (and eyes) up, skywatchers! The annual Perseid meteor shower is underway and will hit its peak this weekend.The meteor shower, so named because the meteors appear to come from the constellation Perseus, lasts for several weeks – from July 17 to Aug. 24 – but peak meteor activity will take place between about 4 p.m. ET on Sunday, Aug. 12 and 4 a.m. on Monday, Aug. 13, according to NASA.During the peak, one can expect to see as many as 60 or 70 meteors per hour.Night sky conditions should be great for meteor viewing: The peak coincides perfectly with the new moon, meaning the sky will be plenty dark and meteors will be easy to spot. Most meteor showers are best after midnight. 702

Hostess announced Tuesday that it has expanded a recall of raspberry Zingers due to the potential of mold.Previously, Hostess announced a recall in June of raspberry Zingers with best by dates in August. The latest recall now includes best by dates in September and October.No other Hostess products are included in the recall.Consumers who have purchased the affected product are urged to discontinue consumption and contact the place of purchase about returning them for a full refund, the company said.Here is an updated list of recalled products: 558